These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9742289)

  • 41. [Tricyclic antidepressants (imipramine, desipramine, amitriptyline, nortriptyline)].
    Yasuda K
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():934-7. PubMed ID: 8753592
    [No Abstract]   [Full Text] [Related]  

  • 42. On the kinetics of imipramine and related antidepressants.
    Nagy A
    Acta Psychiatr Scand Suppl; 1980; 280():147-56. PubMed ID: 6931475
    [No Abstract]   [Full Text] [Related]  

  • 43. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B; Holle L
    Chronobiol Int; 1991; 8(3):176-85. PubMed ID: 1794155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetics of imipramine in children.
    Tamayo M; Fernández de Gatta MM; García MJ; Domínguez-Gil A
    Eur J Clin Pharmacol; 1992; 43(1):89-92. PubMed ID: 1505617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm.
    Besson A; Privat AM; Eschalier A; Fialip J
    Pharmacol Biochem Behav; 1999 Nov; 64(3):541-8. PubMed ID: 10548269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry.
    Rousseau A; Marquet P; Comby F; Buxeraud J; Raby C; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):93-100. PubMed ID: 9200522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J; Wasieczko A
    Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triiodothyronine increases desipramine with changing the concentrations of monoamines, in the brain of rat given imipramine.
    Suzuki S; Yoshida T; Sugita S; Kobayashi A; Nakazawa K
    Eur J Pharmacol; 1993 Feb; 231(2):297-300. PubMed ID: 7681006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adsorptive stripping voltammetric determination of imipramine, trimipramine and desipramine employing titanium dioxide nanoparticles and an Amberlite XAD-2 modified glassy carbon paste electrode.
    Sanghavi BJ; Srivastava AK
    Analyst; 2013 Mar; 138(5):1395-404. PubMed ID: 23324861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo study of the antithyroid side effects of trimeprazine.
    Sauvage MF; Rousseau A; Marquet P; Dumeirain F; Raby C; Lachâtre G
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):125-31. PubMed ID: 10406927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imipramine and tinnitus.
    Tandon R; Grunhaus L; Greden JF
    J Clin Psychiatry; 1987 Mar; 48(3):109-11. PubMed ID: 3818550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunoassay reagents for psychoactive drugs. II. The method for the development of antibodies specific to imipramine and desipramine.
    Adamczyk M; Fishpaugh J; Harrington C; Johnson D; Vanderbilt A
    J Immunol Methods; 1993 Aug; 163(2):187-97. PubMed ID: 8354888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
    Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
    Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyroid function and reversal by antidepressant drugs of depressive-like behavior (escape deficits) in rats.
    Martin P; Massol J; Belon JP; Gaudel G; Soubrié P
    Neuropsychobiology; 1987; 18(1):21-6. PubMed ID: 3444522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification of Tricyclic Antidepressants in Serum Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
    Crutchfield CA; Breaud AR; Clarke WA
    Methods Mol Biol; 2016; 1383():265-70. PubMed ID: 26660194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The analysis and disposition of imipramine and its active metabolites in man.
    Sutfin TA; DeVane CL; Jusko WJ
    Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.